Please assess the completion status of the following clinical trial:

Trial Title: Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult males or females, ages 18 - 75~2. Fitzpatrick skin types 1-6~3. Patient is able to read and understand English and will give written informed consent to participate.~4. Patient elects to undergo laser therapy or conventional therapy with liquid nitrogen for the treatment of verruca vulgaris.~5. Clinical evidence of at least one verruca vulgaris, but no more than ten that have not received treatment for at least one month prior to their study start date.~6. Warts to be treated will be located only on the hands or the feet.~Exclusion Criteria:~1. Less than 18 years of age or greater than 75 years of age.~2. Non-English speaking people, who cannot read, understand and sign the consent.~3. Pregnant females.~4. Any form of prior treatment to the area within the last 1 month.~5. Immunosuppressed patients including patients with internal malignancy, on immunosuppressive drugs (including oral steroids), HIV positive or history of connective tissue disease (ie. SLE, DM, Scleroderma).~6. Patients undergoing light therapy including NBUVB, PUVA, high UVB will be excluded from the study until their treatment is complete.~7. Allergy to any components of the topical lidocaine (LMX, 4% lidocaine).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Liquid Nitrogen Cryotherapy (Type: ACTIVE_COMPARATOR): Every two weeks for a total of 5 treatments or until the patient clears, patients in the cryotherapy arm will be treated with 5-7 seconds of freeze time maintaining a 1mm freeze halo around the wart.
- Pulsed 1064nm Nd:YAG (Type: EXPERIMENTAL): Every 2 weeks for a total of five treatments or until the wart clears, patients in the laser arm will be treated with the Nd:YAG. The settings will be 180J, 20ms pulse width and 5mm spot size. For warts 3mm or less, a 3mm spot size will be used, 180J and 15ms. If the patient reports no response after treatment, including crusting or blistering, the energy will be increased by 10 J until 200J has been reached.

Based on this trial design, predict the completion outcome and termination type (if applicable).